Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aiden Flynn

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Personalized Medicine|May 12, 2018
ExploristicsAiden Flynn
Cancer Biotherapy & Radiopharmaceuticals|August 3, 2004
Nonuniform absorbed dose distribution in the kidney: the influence of organ architectureAlan Green, Aiden Flynn, R Barbara Pedley, et al.
Pharmaceutical Statistics|December 14, 2011
A statistician's perspective on biomarkers in drug developmentMartin Jenkins, Aiden Flynn, Trevor Smart, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 8, 2025
Peer-Led Cancer Education Intervention in Appalachian Kentucky: Evaluating Effects on Participants' Cancer Knowledge and PerspectivesJiwoo Kim, Youngwoo Kim, Jacob Austin, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|August 27, 2015
Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary diseasePuja Kohli, Victor Pinto-Plata, Miguel Divo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2018
Pulmonary <sup>18</sup>F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)Thida Win, Nicholas J Screaton, Joanna C Porter, et al.
The Lancet. Respiratory Medicine|March 16, 2015
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE studyR Gisli Jenkins, Juliet K Simpson, Gauri Saini, et al.
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
Elife|July 15, 2024
Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trialJoanna C Porter, Jamie Inshaw, Vincente Joel Solis, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Personalized Medicine|May 12, 2018
ExploristicsAiden Flynn
Cancer Biotherapy & Radiopharmaceuticals|August 3, 2004
Nonuniform absorbed dose distribution in the kidney: the influence of organ architectureAlan Green, Aiden Flynn, R Barbara Pedley, et al.
Pharmaceutical Statistics|December 14, 2011
A statistician's perspective on biomarkers in drug developmentMartin Jenkins, Aiden Flynn, Trevor Smart, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 8, 2025
Peer-Led Cancer Education Intervention in Appalachian Kentucky: Evaluating Effects on Participants' Cancer Knowledge and PerspectivesJiwoo Kim, Youngwoo Kim, Jacob Austin, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|August 27, 2015
Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary diseasePuja Kohli, Victor Pinto-Plata, Miguel Divo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2018
Pulmonary <sup>18</sup>F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)Thida Win, Nicholas J Screaton, Joanna C Porter, et al.
The Lancet. Respiratory Medicine|March 16, 2015
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE studyR Gisli Jenkins, Juliet K Simpson, Gauri Saini, et al.
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
Elife|July 15, 2024
Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trialJoanna C Porter, Jamie Inshaw, Vincente Joel Solis, et al.
Pageof 1